Gheuens Sarah
Reporting owner on Forms 3, 4 and 5, CIK 1881190.
Gheuens Sarah reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-10-28.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| AGIO · AGIOS PHARMACEUTICALS, INC.CIK 1439222 | officer (Chief Medical Officer) | 2 | 2026-10-28 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| AGIO · AGIOS PHARMACEUTICALS, INC.Common stock | 2026-10-26 | M exercised | +7,866 | $25.01 | 62,511 | Form 4 |
| AGIO · AGIOS PHARMACEUTICALS, INC.Common stock | 2026-10-26 | S sold | -7,866 | $37.69 | 54,645 | Form 4 |
| AGIO · AGIOS PHARMACEUTICALS, INC.Stock options (right to buy), derivative | 2026-10-26 | M exercised | -7,866 | $0 | 16,275 | Form 4 |
| AGIO · AGIOS PHARMACEUTICALS, INC.Common stock | 2026-10-22 | M exercised | +500 | $25.01 | 55,145 | Form 4 |
| AGIO · AGIOS PHARMACEUTICALS, INC.Common stock | 2026-10-22 | S sold | -500 | $37.52 | 54,645 | Form 4 |
| AGIO · AGIOS PHARMACEUTICALS, INC.Stock options (right to buy), derivative | 2026-10-22 | M exercised | -500 | $0 | 24,141 | Form 4 |
| AGIO · AGIOS PHARMACEUTICALS, INC.Common stock | 2026-10-21 | M exercised | +1,489 | $25.01 | 56,134 | Form 4 |
| AGIO · AGIOS PHARMACEUTICALS, INC.Common stock | 2026-10-21 | S sold | -1,489 | $37.53 | 54,645 | Form 4 |
| AGIO · AGIOS PHARMACEUTICALS, INC.Stock options (right to buy), derivative | 2026-10-21 | M exercised | -1,489 | $0 | 24,641 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001439222-26-000124 | AGIOS PHARMACEUTICALS, INC. | 2026-10-28 | ||
| Form 4 0001439222-26-000122 | AGIOS PHARMACEUTICALS, INC. | 2026-10-23 |